Results 101 to 110 of about 202,491 (298)

Post-translational modifications and bronchopulmonary dysplasia

Frontiers in Pediatrics
Bronchopulmonary dysplasia is a prevalent respiratory disorder posing a significant threat to the quality of life in premature infants. Its pathogenesis is intricate, and therapeutic options are limited. Besides genetic coding, protein post-translational
Kun Yang, Ting He, Xue Sun, Wenbin Dong
doaj   +1 more source

Trends in survival among extremely-low-birth-weight infants (less than 1000 g)without significant bronchopulmonary dysplasia [PDF]

, 2015
Objective The aim of this study was to analyze the evolution from 1997 to 2009 of survival without significant (moderate and severe) bronchopulmonary dysplasia (SWsBPD) in extremely-low-birth-weight (ELBW) infants and to determine the influence of ...
Botet Mussons, Francisco, Carbonell i Estrany, Xavier, Figueras Aloy, José, 1950-, Miracle Echegoyen, Xavier, Rodríguez Miguélez, José-Manuel, Salvia-Roiges, Ma Dolors   +5 more
core   +2 more sources

ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis [PDF]

, 2023
Min Yang, Yanping Chen, Xueshan Huang, Fang Shen, Yanni Meng   +4 more
openalex   +1 more source

Phenotypes of Bronchopulmonary Dysplasia

International Journal of Molecular Sciences, 2020
Bronchopulmonary dysplasia (BPD) is the most common chronic morbidity in preterm infants. In the absence of effective interventions, BPD is currently a major therapeutic challenge.
Shih-Hsin Wang, P. Tsao
semanticscholar   +1 more source

Deep learning assessment of fetal brain maturation on 3D ultrasound volumes in early‐onset fetal growth restriction

Ultrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objectives To quantify fetal brain maturation in fetuses with early‐onset fetal growth restriction (FGR) by estimating gestational age (GA) based on the appearance of gyrification and individual brain structures from three‐dimensional (3D) ultrasound volumes using a deep‐learning model trained on optimally developing subjects.
L. Meijerink, M. Wyburd, A. I. L. Namburete, T. Alderliesten, F. Groenendaal, M. Benders, F. Terstappen, M. N. Bekker   +7 more
wiley   +1 more source

Lung interstitial cells during alveolarization [PDF]

Korean Journal of Pediatrics, 2010
Recent progress in neonatal medicine has enabled survival of many extremely low-birth-weight infants. Prenatal steroids, surfactants, and non-invasive ventilation have helped reduce the incidence of the classical form of bronchopulmonary dysplasia ...
Chang Won Choi
doaj   +1 more source

The Airway Microbiome at Birth. [PDF]

, 2016
Alterations of pulmonary microbiome have been recognized in multiple respiratory disorders. It is critically important to ascertain if an airway microbiome exists at birth and if so, whether it is associated with subsequent lung disease.
Aghai, Zubair H., Ambalavanan, Namasivayam, Bhandari, Vineet, Carlo, Waldemar A., Eipers, Peter, Halloran, Brian, Jilling, Tamas, Keeley, Jordan, Kumar, Ranjit, Lal, Charitharth Vivek, Morrow, Casey, Rezonzew, Gabriel, Travers, Colm   +12 more
core   +2 more sources

Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review

Journal of Maternal-Fetal & Neonatal Medicine, 2019
Background Infants born extremely preterm (
C. Siffel, K. Kistler, Juliana F. M. Lewis, S. Sarda   +3 more
semanticscholar   +1 more source

Five‐Minute Apgar Scores and Its Prognostic Value for Mortality and Severe Morbidity in Very Preterm Infants: A Multinational Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To examine associations between a 5‐min Apgar score < 7 and severe neonatal outcomes in very preterm (VPT) infants and how results are impacted by variations in assigning Apgar scores within an international context. Design Prospective observational population‐based cohort study.
Harald Ehrhardt, Soodabeh Behboodi, Rolf F. Maier, Adrien M. Aubert, Ulrika Åden, Elizabeth S. Draper, Anna Gudmundsdottir, Veronica Siljehav, Heili Varendi, Tom Weber, Michael Zemlin, Jennifer Zeitlin, on behalf of the EPICE/SHIPS Research Group, J. Lebeer, P. Van Reempts, E. Bruneel, E. Cloet, A. Oostra, E. Ortibus, I. Sarrechia, K. Boerch, L. Huusom, P. Pedersen, T. Weber, A. Hasselager, L. Toome, H. Varendi, M. Männamaa, P. Y. Ancel, A. Burguet, P. H. Jarreau, V. Pierrat, P. Truffert, R. F. Maier, M. Zemlin, B. Misselwitz, S. Schmidt, L. Wohlers, M. Cuttini, D. Di Lallo, G. Ancora, D. Baronciani, V. Carnielli, I. Croci, G. Faldella, F. Ferrari, F. Franco, G. Gargano, A. van Heijst, C. Koopman‐Esseboom, J. Gadzinowski, J. Mazela, A. Montgomery, T. Pikuła, H. Barros, R. Costa, L. Mendes Graça, M. do Céu Machado, C. Rodrigues, T. Rodrigues, U. Aden, A. K. Edstedt Bonamy, M. Norman, E. S. Draper, E. M. Boyle, A. Fenton, S. J. Johnson, B. N. Manktelow, D. W. A. Milligan, S. Mader, N. Thiele, J. Walz, S. Petrou, J. Zeitlin, M. Bonet, C. Bonnet, R. El Raffei, A. Piedvache, A. V. Seppanen, A. M. Aubert   +79 more
wiley   +1 more source

MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY

Педиатрическая фармакология, 2012
Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations.
I. V. Davydova, T. V. Turti, E. P. Zimina, V. V. Altunin   +3 more
doaj   +1 more source